|
Q4 FY2017
As of Jan 31, 2017
|
Q3 FY2017
As of Oct 31, 2016
|
Q2 FY2017
As of Jul 31, 2016
|
Q1 FY2017
As of Apr 30, 2016
|
Q4 FY2016
As of Jan 31, 2016
|
Q3 FY2016
As of Oct 31, 2015
|
Q2 FY2016
As of Jul 31, 2015
|
Q1 FY2016
As of Apr 30, 2015
|
Q4 FY2015
As of Jan 31, 2015
|
Q3 FY2015
As of Oct 31, 2014
|
Q2 FY2015
As of Jul 31, 2014
|
Q1 FY2015
As of Apr 30, 2014
|
Q4 FY2014
As of Jan 31, 2014
|
Q3 FY2014
As of Oct 31, 2013
|
Q2 FY2014
As of Jul 31, 2013
|
Q1 FY2014
As of Apr 30, 2013
|
Q4 FY2013
As of Jan 31, 2013
|
Q3 FY2013
As of Oct 31, 2012
|
Q2 FY2013
As of Jul 31, 2012
|
Q1 FY2013
As of Apr 30, 2012
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Trade accounts receivable, net of allowance for doubtful accounts of $4,089 as of January 31, 2017 and $3,826 as of January 31, 2016 | ||||||||||||||||||||
| Other receivables | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Prepaid expenses and other | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant, and equipment, net | ||||||||||||||||||||
| Term receivables | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Stockholders' Equity | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Short-term borrowings | ||||||||||||||||||||
| Current portion of notes payable | ||||||||||||||||||||
| Current portion of notes payable (Note 7) | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Accrued payroll and related liabilities | ||||||||||||||||||||
| Accrued and other liabilities | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Notes payable | ||||||||||||||||||||
| Notes payable (Note 7) | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Income tax liability | ||||||||||||||||||||
| Deferred income taxes, long-term | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Convertible notes (Note 5) | ||||||||||||||||||||
| Noncontrolling interest with redemption feature | ||||||||||||||||||||
| Convertible notes (Note 7) | ||||||||||||||||||||
| Stockholders' equity: | ||||||||||||||||||||
| Common stock, no par value, 300,000 shares authorized as of January 31, 2017 and January 31, 2016; 110,383 shares issued and outstanding as of January 31, 2017 and 114,934 shares issued and outstanding as of January 31, 2016 | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Noncontrolling interest | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...
